Comments
Loading...
KalVista Pharma (NASDAQ:KALV) Stock, Earnings Estimates, EPS, And Revenue
KalVista Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Dec 5
EPS Estimate
$-0.910
Quarterly Revenue Estimate
–
Annual Revenue
(as of Jul 31)
(as of Jul 31)
–
Analyze the earnings history of KalVista Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
KalVista Pharma (KALV) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-09-05 | $-0.87 | $-0.86 | -1.16 % |
| Jun 2024 | 2024-07-11 | $-1.02 | $-0.73 | -39.7 % |
| Dec 2023 | 2024-03-11 | $-0.84 | $-0.77 | -9.09 % |
| Sep 2023 | 2023-12-07 | $-0.80 | $-0.79 | -1.27 % |
KalVista Pharma (KALV) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2021 | 2021-07-13 | $0 | $580.00K | -100.0 % |
FAQ
When is KalVista Pharma (NASDAQ:KALV) reporting earnings?
KalVista Pharma (KALV) is scheduled to report earnings on December 5, 2024. The last reported earnings were for reported on September 5, 2024 for Q1.
What were the latest earnings per share (EPS) for KalVista Pharma (NASDAQ:KALV)?
The Actual EPS was $-0.87, which missed the estimate of $-0.86.
What were KalVista Pharma’s (NASDAQ:KALV) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.